I am a
Home I AM A Search Login

Papers of the Week

Papers: 13 Aug 2022 - 19 Aug 2022


2022 Aug 16

J Med Econ

Reductions in Acute Medication Use and Healthcare Resource Utilization in Patients with Chronic Migraine: A Secondary Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab with Open-Label Extension (REGAIN).


To analyze secondary objectives of the REGAIN study related to acute headache medication use and healthcare resource utilization (HCRU) in patients with chronic migraine treated with galcanezumab, a monoclonal antibody to calcitonin gene-related peptide.